Biotechnology - Pharmaceutical


Current filters:


Popular Filters

126 to 150 of 1005 results

US Court denies re-hearing of Arzerra patent case


Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

US FDA approves Boehringer Ingelheim's first cancer drug


In what the family-owned German drug major Boehringer Ingelheim hopes is just the first drug to come…

afatinibBiotechnologyBoehringer IngelheimGilotrifNorth AmericaOncologyPharmaceuticalQiagenRegulation

Conditional EU approval for Roche basal cell carcinoma drug


The European Commission has granted conditional approval to Swiss drug major Roche's (ROG: SIX) Erivedge…


GlaxoSmithKline and Theravance withdraw Japan NDA for Relvar Ellipta in COPD


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) revealed on Friday…

Asia-PacificBiotechnologyGlaxoSmithKlinePharmaceuticalRegulationRelvar ElliptaRespiratory and PulmonaryTheravance

Italy's Chiesi gains rights to uniQure's Glybera


Netherlands-based venture capital backed human gene therapy firm uniQure has signed collaboration agreements…

BiotechnologyChiesi FarmaceuticiGlyberaLicensingMergers & AcquisitionsPharmaceuticaluniQure

Strong uptake of Regeneron/Bayer wet AMD drug Eylea in USA, but Avastin still leads


The majority of wet age-related macular degeneration (AMD) patients are administered their first intravitreal…

AllerganAvastinBayerBiotechnologyEyleaFovistaLucentisMarkets & MarketingNorth AmericaOphthalmicsOphthotechPharmaceuticalRegeneronRoche

EU's IMI launches 9th Call for proposals with 135 million-euro budget


The European Union Innovative Medicines Initiative (IMI) is launching its 9th Call for proposals, with…


Amgen gains rights to Servier's heart drugs ivabradine and S38844


USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, has entered a new collaboration…

AmgenBiotechnologyCardio-vascularEuropeivabradineLicensingNorth Americaomecamtiv mecarbilPharmaceuticalS38844Servier

GlaxoSmithKline files sNDAs for combination melanoma drugs


UK pharma giant GlaxoSmithKline (LSE: GSK) said today (July 9) that it has submitted supplemental New…

BiotechnologyGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

Immunocore in multi-million deal with GlaxoSmithKline on ImmTACs


Oxford, UK-based biotech firm Immunocore, focused on developing novel biological drugs called ImmTACs…


New EULAR recommendations address use of synthetic and biological DMARDs


The European League Against Rheumatism (EULAR) has this week released updated recommendations for the…

ActemraBiotechnologyBristol-Myers SquibbEuropeHealthcareMabTheraOrenciaPfizerPharmaceuticalRegulationRocheXeljanz

EU supports GAPVAC to develop new personalized cancer vaccines with 6 million euros


A highly innovative project supported by a 6 million euros ($7.8 million) European Union Framework 7…

BioNTechBiotechnologyEuropeFinancialimmatics biotechnologiesOncologyPharmaceuticalResearch

EFPIA releases code on financial relations with health care professionals


The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released its disclosure…

BiotechnologyEuropeFinancialMarkets & MarketingPharmaceuticalRegulation

New data support safety and efficacy of Biogen Idec and SOBI's Alprolix


US biotech firm Biogen Idec (Nasdaq: BIIB) and Swedish Orphan Biovitrum (STO: SOBI) yesterday presented…

AlprolixBiogen IdecBiotechnologyPharmaceuticalResearchSwedish Orphan Biovitrum

US FDA backs news indications for Latuda; grants Priority Review for Perjeta


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506), says that…

BiotechnologyDainippon Sumitomo PharmaLatudaNeurologicalNorth AmericaOncologyPerjetaPharmaceuticalRegulationRocheSunovion

Pharming and SIPI collaboration includes Ruconest marketing in China


Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

Seattle Genetics takes up option to co-develop additional ADC with Astellas


Japanese drug major Astellas Pharma (TYO: 4503) says that US biotech firm Seattle Genetics (Nasdaq: SGEN)…

ASG-15MEAstellas PharmaBiotechnologyLicensingOncologyPharmaceuticalSeattle Genetics

Merck Serono sets up new platform for cancer therapies innovation


Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

126 to 150 of 1005 results

Back to top